Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking
2007

Genetic and Smoking Risks for Age-Related Macular Degeneration

Sample size: 667 publication 10 minutes Evidence: high

Author Information

Author(s): Hughes Anne E, Orr Nick, Patterson Chris, Esfandiary Hossein, Hogg Ruth, McConnell Vivienne, Silvestri Giuliana, Chakravarthy Usha

Primary Institution: Queen's University Belfast

Hypothesis

Can genetic factors and smoking history predict the risk of developing neovascular age-related macular degeneration (AMD)?

Conclusion

An individual's risk of developing AMD in old age can be predicted by combining haplotype data with smoking status.

Supporting Evidence

  • Five common haplotypes of CFH conferred a range of odds ratios from 1 to 4.17.
  • Carriage of one copy of a detrimental haplotype increased the risk of AMD nearly 3-fold.
  • The risk of blinding AMD rose to 15.5% in the highest risk group.

Takeaway

Scientists found that your chances of getting a serious eye disease called AMD can be guessed by looking at your genes and whether you smoke.

Methodology

The study involved genotyping polymorphisms in CFH and LOC387715/HTRA1 in a case-control study of 401 patients with neovascular AMD and 266 controls.

Potential Biases

Participants who refused to participate were more likely to be older and female, which may introduce bias.

Limitations

The model needs validation in independent datasets and may not account for rare variants influencing AMD risk.

Participant Demographics

Participants were from Northern Ireland, aged 54 to 100 years, and predominantly of European descent.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 1.91–4.20 for one copy of LOC387715/HTRA1 haplotype

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pmed.0040355

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication